CROHN'S DISEASE: AN ECONOMIC ASSESSMENT OF BIOLOGICAL DRUGS IN ITALY

被引：0
|
作者：
Cicchetti, A. [1 ]
Gasbarrini, A. [1 ]
Ruggeri, M. [1 ]
机构：
[1] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1117
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A497 / A498
页数：2
相关论文
共 50 条
  • [1] Review article: biological drugs in Crohn's disease
    Kamm, M. A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 : 80 - 89
  • [2] An economic comparison of biological therapies for Crohn's disease
    Cohen, RD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S275 - S275
  • [3] Economic implications of biological therapy for Crohn's disease
    Petryszyn, Pawel W.
    Paradowski, Leszek
    PRZEGLAD GASTROENTEROLOGICZNY, 2015, 10 (04): : 197 - 202
  • [4] Economic implications of biological therapies for Crohn's disease - Review of infliximab
    Bodger, K
    PHARMACOECONOMICS, 2005, 23 (09) : 875 - 888
  • [5] Biological therapy in Crohn's disease
    Gordon, JN
    MacDonald, TT
    HOSPITAL MEDICINE, 2003, 64 (12): : 708 - 712
  • [6] Biological Treatment of Crohn's Disease
    Nielsen, Ole Haagen
    Bjerrum, Jacob Tveiten
    Seidelin, Jakob Benedict
    Nyberg, Caroline
    Ainsworth, Mark
    DIGESTIVE DISEASES, 2012, 30 : 121 - 133
  • [7] Assessment of biological agents in the treatment regimen of moderate to severe Crohn's disease
    Chau, Ngoc-Anh
    Romero, Deandra
    Toolsie, Priya
    Jimmy, Jiny
    Bleidt, Barry A.
    PHARMACOTHERAPY, 2015, 35 (11): : E299 - E300
  • [8] A Systematic Review of Economic Studies on Biological Agents Used to Treat Crohn's Disease
    Tang, Derek H.
    Harrington, Amanda R.
    Lee, Jeannie K.
    Lin, Mark
    Armstrong, Edward P.
    INFLAMMATORY BOWEL DISEASES, 2013, 19 (12) : 2673 - 2694
  • [9] The cost of Crohn's disease - Drugs or surgery?
    Cohen, RD
    BIODRUGS, 2000, 14 (05) : 331 - 344
  • [10] Emerging drugs to treat Crohn's disease
    Strauch, Ulrike
    Schoelmerich, Juergen
    EXPERT OPINION ON EMERGING DRUGS, 2010, 15 (02) : 309 - 322
12345